Position in JNJ
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,090,801
-$30,337,583 QoQ
Shares Held
4,295
-96.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,932
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEDGE CAPITAL MANAGEMENT L L P/NC holds $67,797,573 across 8 Drug Manufacturers - General names. JNJ ranks #3 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
134,579 | $33,865,459 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
528,057 | $30,426,644 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
4,295 | $1,090,801 | |
| 4 | LLY |
ELI LILLY & Co
|
764 | $916,364 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,873 | $626,180 | |
| 6 | PFE |
Pfizer Inc
|
13,423 | $323,225 | |
| 7 | AMGN |
Amgen Inc
|
840 | $304,180 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,937 | $244,720 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,090,801 | 4,295 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $31,428,384 | 128,573 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $28,953,339 | 139,905 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $27,904,041 | 150,491 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $625,664 | 4,096 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $665,847 | 4,015 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $584,120 | 4,039 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $654,560 | 4,039 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $577,770 | 3,953 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $681,798 | 4,310 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $652,822 | 4,165 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $282,842 | 1,816 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $719,846 | 4,349 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $699,825 | 4,515 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $793,865 | 4,494 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $722,051 | 4,420 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $801,457 | 4,515 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $35,308,115 | 199,222 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $34,343,842 | 200,759 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $29,562,413 | 183,049 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $31,630,574 | 192,003 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $32,129,931 | 195,497 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $30,976,790 | 196,828 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $28,881,826 | 193,994 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $33,995,614 | 241,738 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $31,793,648 | 242,459 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||